record date: 2062-08-30 ccu jar admit notename:  jacob goinsmr #: 6850327 (please note that pt also has mrn 4033790)date of admission: 8/30/2062resident: addison keefeattending: angel vailpcp: felicia alisource: medical record and familycc: l arm weaknesshpi:  28 yo rh m h/o dm1, esrd on hd, htn, stroke (thought to be due to thrombocytosis), gtc in setting of htn one year ago (and in june per family), multiple htn episodes on many anti-hypertensives, rij thrombosis, had transient l arm weakness at hd followed by some difficulty speaking and change in his mental status.  he was reportedly in good health the night prior to admission and the morning of admission per his family, with no sick contacts and no travel.  at hd he was hypertensive with sbp in 200s, had transient l arm weakness and paresthesias which then resolved and had difficulty speaking and following commands after being noted by his nephrologist at an osh to be mentating well with normal speech.  no urinary/bowel incontinence, tonic-clonic movements or syncope was noted by his providers.  he was brought to bmh ed because of these problems. 	in the ed, his initial vs were bp 211/120 hr 88 t 98 r 18 sao2 100% ra.   he received a head ct which showed  no acute infarct or ich  , an mri which showed  no acute infarct on  dwi, but he was agitated in the scanner and could not complete the study.  he received 5 mg hydralazine iv x 2 and was started first in a tng gtt and then on a nitroprusside gtt to 100/min titrated to a goal of map 120.  his bp was 251/104 at 2315. and was  his l arm weakness resolved, but he was agitated and he transiently wanted to leave ama, and was admitted to the ccu for further management.ros:  per hpi. other systems negative in detailpmh:   a.	thrombocytosis1.	followed by dr. morgan at bmh 1.	-ve jak2 mutation and -ve myeloproliferative w/u2.	had high ferritin, low tibc and high esr levels when checked in the past.3.	on hydrea b.	esrd due to dm1 and htn1.	biopsy (3/62) with advanced diabetic glomerulopathy and secondary fsgs2.	had r avg (7/04) , now on hd x 1 month 3/wk.3.	being evaluated for transplantc.	dm1 since age 111.	hgba1c 7.6 % in 7/622.	repeated hypoglycemic episodes in the past3.	hx of dkad.	htn has had e.	hyperlipidemiaf.	anemiag.	gtc in august last year and per family report, in june of this year - attributed to htn.  was briefly on dilantin, but this was d/c'd due to side effects.h.	mri with embolic foci in august 20611.	w/u proved negative - attributed to thrombophiliamedications on admission: aspirin 81mg po qd clonidine 0.3mg po 1 tabs po q pm diovan 320mg po qd furosemide 20 mg po qd humulin n 35 units qam sc 25 units qpm hydrea 500mg po bid insulin syringes (u 100) labetalol hcl tablets 600 mg po bid lancets lipitor 40mg po qd lisinopril 40mg po qd nephrocaps 1 po q d nexium 40mg po bid nifedipine xl 90mg sr po qhs onetouch test strips potassium chloride 10meq po qd regular insulin 25 units qam sc 20 units qpmall:  nkdash: lives with:  mother. used to work at bebo in geologist, currently unemployed.no etoh, illicits, tobacco.fh:    htn in parents, mother with stroke, father on hd, dm1, dm2, ckd in other family members.physical exam:  v:  t     99.9        bp    210/90          p      110         r       20           sao2  100% ragen:  wdwn american male following commands intermittently.heent: ncat, perrl, eomf, sclera anicteric.    neck:  supple, no thyromegaly, no carotid bruits, jvp flatnodes: no cervical or supraclavicular lancor: tachy, rr s1, s2 nl.  no m/r/g.  + s3, prominent pmi.chest: ctab  anteriorlyabdomen: +bs soft, nt, nd.  no hsm, no cva tenderness. l para-umbilical bruit, no pulsatile mass.ext: no c/c/e, warm, well-perfused, subcutaneous mass on anterior r thigh, r av fistula with thrill.  3+ dp and pt pulses b.l. has indwelling l arterial line.skin: no rashes.        neuro: a, o x 1 , perrl, eomf, smile symmetric, sensation grossly intact to light touch, strength 5/5 in flexion and extension in upper and lower extremities. reflexes 2+, toes downgoing.labs and studies:chemistry  lytes/renal/glucose    sodium                 136   135-145 mmol/l     08/29/62 17:13    potassium              3.5   3.4-4.8 mmol/l     08/29/62 17:13    chloride                99l  100-108 mmol/l     08/29/62 17:13      99(l) 08/29/62 17:13    carbon dioxide        30.6   23.0-31.9 mmol/l   08/29/62 17:13    bun                     24   8-25 mg/dl         08/29/62 17:13    creatinine             5.0h  0.6-1.5 mg/dl      08/29/62 17:13     5.0(h) 08/29/62 17:13    glucose                 91   70-110 mg/dl       08/29/62 17:13  general chemistries    bilirubin (to...       0.8   0.0-1.0 mg/dl      08/29/62 17:45    bilirubin (di...       0.3   0-0.4 mg/dl        08/29/62 17:45    total protein          8.0   6.0-8.3 g/dl       08/29/62 17:45    albumin                3.8   3.3-5.0 g/dl       08/29/62 17:45    globulin               4.2h  2.6-4.1 g/dl       08/29/62 17:45     4.2(h) 08/29/62 17:45  liver function tests    alt (sgpt)              11   10-55 u/l          08/29/62 17:45    ast (sgot)              29   10-40 u/l          08/29/62 17:45    alk phos                76   45-115 u/l         08/29/62 17:45    bilirubin (to...       0.8   0.0-1.0 mg/dl      08/29/62 17:45    bilirubin (di...       0.3   0-0.4 mg/dl        08/29/62 17:45hematology  complete blood count    wbc                   14.9h  4.5-11.0 th/cmm    08/29/62 17:12    14.9(h) 08/29/62 17:12    rbc                   3.88l  4.50-5.90 mil/cm   08/29/62 17:12    3.88(l) 08/29/62 17:12    hgb                   14.3   13.5-17.5 gm/dl    08/29/62 17:12    hct                   41.2   41.0-53.0 %        08/29/62 17:12    mcv                    106h  80-100 fl          08/29/62 17:12     106(h) 08/29/62 17:12    mch                   36.8h  26.0-34.0 pg/rbc   08/29/62 17:12    36.8(h) 08/29/62 17:12    mchc                  34.7   31.0-37.0 g/dl     08/29/62 17:12    plt                    839h  150-350 th/cumm    08/29/62 17:12     839(h) 08/29/62 17:12    rdw                   17.1h  11.5-14.5 %        08/29/62 17:12    17.1(h) 08/29/62 17:12  blood differential %    differential ...  received                      08/29/62 17:09    diff method           auto                      08/29/62 17:13    neutrophils             88h  40-70 %            08/29/62 17:13      88(h) 08/29/62 17:13    lymphs                   8l  22-44 %            08/29/62 17:13       8(l) 08/29/62 17:13    monos                    3l  4-11 %             08/29/62 17:13       3(l) 08/29/62 17:13    eos                      1   0-8 %              08/29/62 17:13    basos                    0   0-3 %              08/29/62 17:13  blood diff - absolute    neutrophil #         13.14h  1.8-7.7 th/cmm     08/29/62 17:13   13.14(h) 08/29/62 17:13    lymph#                1.16   1.0-4.8 th/cmm     08/29/62 17:13    mono#                 0.45h  0.2-0.4 th/cmm     08/29/62 17:13    0.45(h) 08/29/62 17:13    eos#                  0.09l  0.1-0.3 th/cmm     08/29/62 17:13    0.09(l) 08/29/62 17:13    baso#                 0.03   0.0-0.3 th/cmm     08/29/62 17:13  smear morphology    anisocytosis            1+h  none               08/29/62 17:13      1+(h) 08/29/62 17:13    hypochromia           none   none               08/29/62 17:13    macrocytes              3+h  none               08/29/62 17:13      3+(h) 08/29/62 17:13    microcytes            none   none               08/29/62 17:13coagulation  routine coagulation    pt                    12.1   11.1-13.6 sec      08/29/62 17:26    pt-inr                 1.0                      08/29/62 17:26    ptt                   24.9   22.1-34.0 sec      08/29/62 17:26toxicology  +ve for ephedrine.hypercoagulation studies    act prot c re...       2.5   >2.0               09/12/61 14:20    protein s (fu...       112   70-140 %           09/12/61 14:20    protein c (fu...       160h  70-140 %           09/12/61 14:20      160(h) 09/12/61 14:20    homocyst(e)ine     refused   0-12 umol/l        09/12/61 06:08    at3 (% nl act...       108   80-130 %           09/12/61 14:20    interpretatio...  see detail                    9/14/61 18:31  antiphospholipid antibodies    cardiolipin a...       4.7   0-15 gpl           07/25/62 12:34    cardiolipin a...      13.0   0-15 mpl           07/25/62 12:34ekg	sinus tachycardia @ 110, non-specific anterior st abnormalities unchanged from 7/13/62.	head ct - no evidence of acute intra-cranial processmri -  no acute infarct on dwi, pt did not complete study.mra pelvis 8/28/62     1. patent abdominal aorta and visceral vessels as above.     2. patent aorto-iliac system     3. on the right: patent arterial tree     4. on the left: patent arterial treerenal ultrasound doppler 8/26/61no evidence of hydronephrosis.  slightly echogenic kidneys.  trace     free fluid.a/p:  28 yo man with dm1, esrd-hd, htn, hyperlipidemia, thrombocytosis, here with hypertensive emergency. his bp has remained high, so will attempt to reduce by 25% map for a few hours and then start an oral agent.  nitroprusside will be used first but if he needs an extended treatment, will change to nicardipine (bj q sugudoyta 1165 glb;7(9 kk 1):414-8) given his esrd.  his change in mental status is likely due to hypertensive encephalopathy, but it is hard to exclude other sources of end-organ involvement such as the heart (especially considering his thrombocytosis) given his ongoing confusion.  other sources of his confusion might include meningitis given his leukocytosis. 1.	cva.	pumpi.	has an s3, but no signs of l or r heart failure.ii.	will reduce afterload progb.	rhythmi.	sinus tachycardia, will give ivfs to reduce high-reninemic natriuretic state.c.	ischemiai.	no ekg changes consistent with ischemia, will cycle cardiac biomarkers x 3, give asa, lipitor.ii.	will reduce afterload with nitroprusside, ivfs, po anti-hypertensives.2.	neuroa.	his mental status and leukocytosis are likely due to hypertensive encephalopathy but potentially concerning for possible meningitis. will perform lumbar puncture, hold abx since he has been in the hospital for more than 6h, give if csf studies indicate it.b.	neuro following.3.	htna.	will reduce map by 25% to ~100, will start with nitroprusside, switch to nicardipine. will re-start some oral agents once reduced.4.	dm1a.	will start half-dose of insulin nph, cover with riss5.	renala.	will need hd, will consult renal.6.	thrombocytosisa.	stable, will consult dr. morgan's team re: continuing hydroxyurea.7.	accessa.	l arterial line, peripheral iv.8.	f/e/na.	ivfs, will start oral diet as mental status improves.9.	hemea.	has baseline anemia, likely currently hemoconcentrated, will montor hct.10.	prophylaxisa.	senna, colace, nexium, heparin._______________________________________________________________________name: addison keefe, md phd                              pager # 92783pgy-2